Sangamo BioSciences | 净收入





净收入 更改 日
Alaunos Therapeutics USD -1.16M 417K 2025-09
Alnylam Pharmaceuticals USD 251.08M 317.36M 2025-09
Alterity Therapeutics Limited AUD -5.77M 2.26M 2023-06
Amgen USD 1.33B 1.88B 2025-12
Bayer EUR -963M 764M 2025-09
BioCryst Pharmaceuticals USD -88.88M 74.85M 2024-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
Cipla INR 6.76B 6.75B 2025-12
Clal Biotechnology ILS -6.17M 15.56M 2022-12
Compugen USD -6.98M 360K 2025-09
CSL USD 497.5M 1.51B 2025-06
Gilead Sciences USD 3.05B 1.09B 2025-09
GlaxoSmithKline GBP 636M 1.38B 2025-12
Grifols EUR 148.4M 15.76M 2025-09
Ionis Pharmaceuticals USD -128.61M 252.16M 2025-09
J&J USD 5.12B 36M 2025-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Merck USD 2.96B 2.82B 2025-12
Novartis USD 3.93B 96M 2025-09
Omeros USD -32.23M 23.81M 2024-09
Pfizer USD -1.65B 5.19B 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR -801M 3.6B 2025-12
Sarepta Therapeutics USD -179.95M 376.84M 2025-09
Tectonic Therapeutic USD -19.04M 940K 2025-09
Ultragenyx Pharmaceutical USD -180.41M 65.46M 2025-09
Vertex Pharmaceuticals USD 1.08B 50M 2025-09


Sangamo BioSciences 净收入 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.